Talk to us?

Periodontics - NEETMDS- courses
NEET MDS Lessons
Periodontology

Aggressive periodontitis (AP) is a multifactorial, severe, and rapidly progressive form of periodontitis that primarily affects younger patients. It is characterized by a unique set of clinical and microbiological features that distinguish it from other forms of periodontal disease.

Key Characteristics

  • Rapid Progression: AP is marked by a swift deterioration of periodontal tissues.
  • Age Group: Primarily affects adolescents and young adults, but can occur at any age.
  • Multifactorial Etiology: Involves a combination of microbiological, immunological, genetic, and environmental factors.

Other Findings

  • Presence of Aggregatibacter actinomycetemcomitans (A.a.) in diseased sites.
  • Abnormal host responses, including impaired phagocytosis and chemotaxis.
  • Hyperresponsive macrophages leading to exaggerated inflammatory responses.
  • The disease may exhibit self-arresting tendencies in some cases.

Classification

Aggressive periodontitis can be classified into two main types:

  1. Localized Aggressive Periodontitis (LAP): Typically affects the permanent molars and incisors, often with localized attachment loss.
  2. Generalized Aggressive Periodontitis (GAP): Involves more widespread periodontal tissue destruction.

Risk Factors

Microbiological Factors

  • Aggregatibacter actinomycetemcomitans: A primary pathogen associated with LAP, producing a potent leukotoxin that kills neutrophils.
  • Different strains of A.a. produce varying levels of leukotoxin, with highly toxic strains more prevalent in affected individuals.

Immunological Factors

  • Human Leukocyte Antigens (HLAs): HLA-A9 and B-15 are candidate markers for aggressive periodontitis.
  • Defective neutrophil function leads to impaired chemotaxis and phagocytosis.
  • Hyper-responsive macrophage phenotype, characterized by elevated levels of PGE2 and IL-1β, may contribute to connective tissue breakdown and bone loss.

Genetic Factors

  • Familial clustering of neutrophil abnormalities suggests a genetic predisposition.
  • Genetic control of antibody responses to A.a., with variations in the ability to produce protective IgG2 antibodies.

Environmental Factors

  • Smoking is a significant risk factor, with smokers experiencing more severe periodontal destruction compared to non-smokers.

Treatment Approaches

General Considerations

  • Treatment strategies depend on the type and extent of periodontal destruction.
  • GAP typically has a poorer prognosis compared to LAP, as it is less likely to enter spontaneous remission.

Conventional Periodontal Therapy

  • Patient Education: Informing patients about the disease and its implications.
  • Oral Hygiene Instructions: Reinforcing proper oral hygiene practices.
  • Scaling and Root Planing: Removal of plaque and calculus to control local factors.

Surgical Resection Therapy

  • Aimed at reducing or eliminating pocket depth.
  • Contraindicated in cases of severe horizontal bone loss due to the risk of increased tooth mobility.

Regenerative Therapy

  • Potential for regeneration is promising in AP cases.
  • Techniques include open flap surgical debridement, root surface conditioning with tetracycline, and the use of allogenic bone grafts.
  • Recent advances involve the use of enamel matrix proteins to promote cementum regeneration and new attachment.

Antimicrobial Therapy

  • Often required as adjunctive treatment to eliminate A.a. from periodontal tissues.
  • Tetracycline: Administered in various regimens to concentrate in periodontal tissues and inhibit A.a. growth.
  • Combination Therapy: Metronidazole combined with amoxicillin has shown efficacy alongside periodontal therapy.
  • Doxycycline: Used at a dose of 100 mg/day.
  • Chlorhexidine (CHX): Irrigation and home rinsing to control bacterial load.

Host Modulation

  • Involves the use of sub-antimicrobial dose doxycycline (SDD) to prevent periodontal attachment loss by modulating the activity of matrix metalloproteinases (MMPs), particularly collagenase and gelatinase.

Stage I: Initial Lesion

  • Cellular Infiltrate: Polymorphonuclear neutrophils (PMNs) present
  • Timeframe: Develops within 2-4 days of plaque accumulation
  • Characteristics: Subclinical changes, increased vascular permeability

Stage III: Established Lesion

  • Duration: Develops after 2-3 weeks of continuous plaque exposure
  • Cellular Changes: Plasma cell dominance, collagen destruction
  • Clinical Features: Frank gingivitis with erythema, edema, and bleeding on probing

ANUG (Acute Necrotizing Ulcerative Gingivitis)

Microbiology

  • Primary Organisms: Spirochetes and Prevotella species
  • Pathogenesis: Opportunistic infection in compromised host defense

Demographics

  • Primary Population: Young adults (20-30 years)
  • Risk Factors: Stress, smoking, malnutrition, immunocompromise

Clinical Presentation

  • Pathognomonic Sign: Crater-like depressions on interdental papilla
  • Additional Features: Spontaneous bleeding, halitosis, lymphadenopathy
  • Pain: Severe, spontaneous gingival pain

Staging System (7 Stages)

  1. Stages 1-2: Necrotizing Ulcerative Gingivitis (NUG)
  2. Stages 3-4: Necrotizing Ulcerative Periodontitis (NUP)
  3. Stages 5-6: Necrotizing Stomatitis
  4. Stage 7: Noma (cancrum oris) - life-threatening condition

  • Mobility Tests: Perio test, Fremitus test.
  • Bone Evaluation: Transgingival probing.
  • Halitosis Detection: Gold standard = Organoleptic analysis.
  • Indices:
    • PMA Index: Gingival disease.
    • Ramfjord Index Teeth: 16, 21, 24, 36, 41, 44.
    • Merin’s Classification: Patient recall.
    • Surrogate Endpoint: Reduction in probing depth.

Feature Details
First valvular lesion Mitral regurgitation
Commonest valve Mitral (especially in children)
Minor criteria Fever (Modified Jones Criteria)
Subcutaneous nodules Non-tender, extensor surfaces
Erythema marginatum Associated with carditis
Diagnostic marker Aschoff's nodule
McCallum's patch Rheumatic endocarditis indicator

Systemic Antibiotics

  • Most photosensitizing: Doxycycline
  • Only one causing tooth discoloration: Minocycline

Local Drug Delivery

  • Atridox: Doxycycline
  • Arestin: Minocycline
  • Elyzol: Metronidazole
  • Periochip: Chlorhexidine
  • Actisite: Tetracycline

Host Modulation

  • SDD (Sub – antimicrobial Dose Doxycycline): Only FDA – approved host modulating agent

ANUG (Acute Necrotizing Ulcerative Gingivitis)

  • Signs: Punched – out crater depressions of interdental papilla
  • Symptoms: Metallic foul taste, pasty saliva
  • Treatment: 3 visits (2nd visit: 1 – 2 days after 1st; 3rd visit: 5 days after 2nd)

NUG/NUP

  • No pocket formation (destroys junctional epithelium)

Primary Herpetic Gingivostomatitis

  • Cellular change: Ballooning degeneration → Tzanck cells
  • Treatment:
    • Within 3 days: Acyclovir 15 mg/kg × 5 times × 7 days
    • After 3 days: Supportive care with NSAIDs

Leukemic Gingivitis

  • Most common in acute monocytic leukemia

Lead Intoxication

  • Steel gray linear pigmentation (Burton's line)

Epithelial Turnover Rates in Oral Tissues

Epithelial turnover is a critical process in maintaining the health and integrity of oral tissues. Understanding the turnover rates of different epithelial types in the oral cavity can provide insights into their regenerative capabilities and responses to injury or disease.

Turnover Rates of Oral Epithelial Tissues

  1. Junctional Epithelium:

    • Turnover Rate: 1-6 days
    • Description:
      • The junctional epithelium is a specialized epithelial tissue that forms the attachment between the gingiva and the tooth surface.
      • Its rapid turnover rate is essential for maintaining a healthy seal around the tooth and for responding quickly to inflammatory changes or injury.
  2. Palate, Tongue, and Cheeks:

    • Turnover Rate: 5-6 days
    • Description:
      • The epithelial tissues of the hard palate, tongue, and buccal mucosa (cheeks) have a moderate turnover rate.
      • This relatively quick turnover helps maintain the integrity of these surfaces, which are subject to mechanical stress and potential injury from food and other environmental factors.
  3. Gingiva:

    • Turnover Rate: 10-12 days
    • Description:
      • The gingival epithelium has a slower turnover rate compared to the junctional epithelium and the epithelium of the palate, tongue, and cheeks.
      • This slower rate reflects the need for stability in the gingival tissue, which plays a crucial role in supporting the teeth and maintaining periodontal health.

Clinical Significance

  • Wound Healing:

    • The rapid turnover of the junctional epithelium is particularly important in the context of periodontal health, as it allows for quick healing of any disruptions caused by inflammation or mechanical trauma.
  • Response to Disease:

    • Understanding the turnover rates can help clinicians anticipate how quickly tissues may respond to treatment or how they may regenerate after surgical procedures.
  • Oral Health Maintenance:

    • The varying turnover rates highlight the importance of maintaining good oral hygiene practices to support the health of these tissues, especially in areas with slower turnover rates like the gingiva.

Explore by Exams